Patents by Inventor Aurelian Radu

Aurelian Radu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of FSH receptor ligands for diagnosis and therapy of cancer
    Patent number: 9200076
    Abstract: The present invention relates to diagnostic imaging and in particular to the diagnostic imaging and therapy of cancer by means of compositions which specifically target the FSH Receptor expressed by tumor endothelial cells and circulating blood cells.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: December 1, 2015
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Inventors: Nicolae Ghinea, Aurelian Radu
  • USE OF FSH RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF CANCER
    Publication number: 20140328758
    Abstract: The present invention relates to diagnostic imaging and in particular to the diagnostic imaging and therapy of cancer by means of compositions which specifically target the FSH Receptor expressed by tumor endothelial cells and circulating blood cells.
    Type: Application
    Filed: July 17, 2014
    Publication date: November 6, 2014
    Inventors: NICOLAE GHINEA, AURELIAN RADU
  • Use of FSH receptor ligands for diagnosis and therapy of cancer
    Patent number: 8784776
    Abstract: The present invention relates to diagnostic imaging and in particular to the diagnostic imaging and therapy of cancer by means of compositions which specifically target the FSH Receptor expressed by tumor endothelial cells and circulating blood cells.
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: July 22, 2014
    Assignees: Inserm (Institut National de la Sante et de la Recherche Medicale), Mount Sinai School of Medicine
    Inventors: Nicolae Ghinea, Aurelian Radu
  • NOVEL METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH A TUMOR TO A TREATMENT WITH A TYROSINE KINASE INHIBITOR
    Publication number: 20130131136
    Abstract: The present invention relates to a method for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor such as sunitinib. More specifically, the method of the invention comprises a step of determining the expression level of one marker consisting of the FSHR in a biological sample obtained from said patient, and more specifically in the blood endothelial cells from the tumors.
    Type: Application
    Filed: August 1, 2011
    Publication date: May 23, 2013
    Inventors: Nicolae Ghinea, Aurelian Radu
  • USE OF FSH RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF CANCER
    Publication number: 20100316572
    Abstract: The present invention relates to diagnostic imaging and in particular to the diagnostic imaging and therapy of cancer by means of compositions which specifically target the FSH Receptor expressed by tumor endothelial cells and circulating blood cells.
    Type: Application
    Filed: February 18, 2009
    Publication date: December 16, 2010
    Applicants: Institut National De La Sante Et De La Recherche Medicale (Inserm), Mount Sinai School of Medicine
    Inventors: Nicolae Ghinea, Aurelian Radu